SCHEMBL29077294

SCHEMBL29077294

ClCc1nnc(-c2cccc(Br)c2)o1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.65
LMNA P02545 1/20 0.65
RAB9A P51151 7/20 0.63
NPC1 O15118 6/20 0.63
SMN1; SMN2 Q16637 3/20 0.63
TP53 P04637 2/20 0.63
TSHR P16473 2/20 0.63
KMT2A Q03164 3/20 0.61
MEN1 O00255 2/20 0.61
CYP1A2 P05177 1/20 0.61
NOTUM Q6P988 3/20 0.58
MAPT P10636 4/20 0.56
KDM4E B2RXH2 3/20 0.56
GAA P10253 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
PTK2 Q05397 1/20 0.55
BCHE P06276 1/20 0.50
ACHE P22303 1/20 0.50
HSD17B10 Q99714 1/20 0.46
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30566780 1.00 ALDH1A1 (0.65) ALDH1A1LMNARAB9ANPC1SMN1; SMN2
SCHEMBL23368032 0.84 RAB9A (0.63) ALDH1A1LMNARAB9ANPC1SMN1; SMN2
SCHEMBL6364718 0.82 RAB9A (0.89) ALDH1A1RAB9ANPC1SMN1; SMN2TP53
SCHEMBL1545045 0.82 ALDH1A1 (0.67) ALDH1A1LMNARAB9ANPC1SMN1; SMN2
SCHEMBL30566753 0.82 ALDH1A1 (0.67) ALDH1A1LMNARAB9ANPC1SMN1; SMN2
SCHEMBL30566768 0.81 LMNA (0.65) ALDH1A1LMNARAB9ANPC1SMN1; SMN2
SCHEMBL1544503 0.81 LMNA (0.65) ALDH1A1LMNARAB9ANPC1SMN1; SMN2
SCHEMBL30566766 0.81 ALDH1A1 (0.65) ALDH1A1LMNARAB9ANPC1SMN1; SMN2
SCHEMBL31413771 0.81 ALDH1A1 (0.65) ALDH1A1LMNARAB9ANPC1SMN1; SMN2
SCHEMBL28531936 0.81 LMNA (0.65) ALDH1A1LMNARAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240300932-A1 N-PHENYLIMINE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF GUIZHOU UNIVERSITY (CN) 2024-09-12 US disclosed
WO-2024174317-A1 N-PHENYLIMINE-CONTAINING DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF 贵州大学 2024-08-29 WO disclosed
CN-116731003-A N-phenylimine-containing derivative, and preparation method and application thereof 贵州大学 2023-09-12 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240300932-A1 N-PHENYLIMINE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF PNMT, NNMT, PAH ALDH1A1 780/4885LMNA 2548/4885RAB9A 4798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.